Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/ASTRAZENECA-PLC-4000930/news/Rilvegostomig-Astrazenecas-biospezifischer-Antikorper-der-von-Compugens-Com902-abgeleitet-ist-wi-42993118/?utm_source=whatsapp&utm_medium=social&utm_campaign=share